Comments on: FDA AdComm #2 on inhaled ciprofloxacin (11 Jan 2018); IMI Call for AMR diagnostics (28 Feb 2018 deadline)

Comments on: FDA AdComm #2 on inhaled ciprofloxacin (11 Jan 2018); IMI Call for AMR diagnostics (28 Feb 2018 deadline) https://i-00ad6e92fcac1838b.amr.solutions/2017/12/03/fda-adcomm-2-on-inhaled-ciprofloxacin-11-jan-2018-imi-call-for-amr-diagnostics-28-feb-2018-deadline/ Antimicrobial Resistance Solutions with Dr. John H. Rex Sat, 10 Jan 2026 16:34:16 +0000 hourly 1